Suchergebnisse

search

Such-Filter

Tag
cardiology
Logo - Lungpacer - Blue.png
Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer
24. März 2025 07:00 ET | Lungpacer Medical USA Inc.
Lungpacer Medical Appoints Medical Device and Healthcare Industry Veteran with 20 Years of Experience as CCO
Stereotaxis Logo - New Tagline - Black Text.png
Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program
19. März 2025 08:01 ET | Stereotaxis, Inc.
ST. LOUIS, March 19, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that NVIDIA...
Lungpacer Announces IDE for STARI Clinical Study
Lungpacer Medical Announces Investigational Device Exemption (IDE) for STARI, Phase 2 Feasibility Clinical Trial
10. März 2025 07:00 ET | Lungpacer Medical USA Inc.
Lungpacer Medical is excited to announce approval of an Investigational Device Exemption (IDE) from the U.S. FDA for the STARI clinical study.
Stereotaxis Logo - New Tagline - Black Text.png
Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance
03. März 2025 07:31 ET | Stereotaxis, Inc.
ST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced FDA...
Heartflow Unveils Bold New Vision for Management of Coronary Artery Disease
25. Februar 2025 08:00 ET | HeartFlow Holding, Inc.
MOUNTAIN VIEW, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the global leader in AI technology for coronary artery disease (CAD) management, today introduced its new brand identity...
George Medicines Logo.JPG
George Medicines appoints Amy Carroll as Senior Vice President of Medical Affairs
03. Februar 2025 07:00 ET | George Medicines
George Medicines appoints Amy Carroll as Senior Vice President of Medical Affairs London, UK, 3 February 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing...
Stereotaxis Logo - New Tagline - Black Text.png
Stereotaxis Announces First GenesisX Robotic System Order
30. Januar 2025 08:09 ET | Stereotaxis, Inc.
ST. LOUIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it has...
Stereotaxis Logo - New Tagline - Black Text.png
Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology
14. Januar 2025 07:21 ET | Stereotaxis, Inc.
ST. LOUIS, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
LOGO Updated.png
SS Innovations International Performs World's First Robotic Cardiac Telesurgeries with its SSi Mantra 3
13. Januar 2025 08:00 ET | SS Innovations
SS Innovations International Performs World's First Robotic Cardiac Telesurgeries with its SSi Mantra 3
George Medicines Logo.JPG
George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Colombia and Central America
13. Januar 2025 07:00 ET | George Medicines
George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Colombia and Central AmericaBausch Health gains exclusive rights to single-pill triple...